Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate
博士 === 國立臺灣大學 === 藥理學研究所 === 84 === In human prostate, both nifedipine and CEC produced significant inhibition of NA-induced contractions. These results indicated that NA-induced contractions in human prostate are mediated by both α1A- and α 1...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
1996
|
Online Access: | http://ndltd.ncl.edu.tw/handle/66140564711167482123 |
id |
ndltd-TW-084NTU00550003 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-084NTU005500032016-07-13T04:10:55Z http://ndltd.ncl.edu.tw/handle/66140564711167482123 Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate 人類前列腺組織a1-腎上腺受體亞型及其拮抗劑藥理作用之探討 Guh Jih-Hwa 顧記華 博士 國立臺灣大學 藥理學研究所 84 In human prostate, both nifedipine and CEC produced significant inhibition of NA-induced contractions. These results indicated that NA-induced contractions in human prostate are mediated by both α1A- and α 1B- adrenoceptorsubtypes. In contrast, the putative α 1a- adrenoceptors in human prostate may be functionally confined to the synaptic region. Ouabain (1uM) did not induce contractile response per se but progressively increased the resting tone in human prostate. Form our experimental results it is suggested that the increased tone of human prostate following repeated excitation in the presence of ouabain is due to increased Ca2+entry and reduced efflux of Ca2+as a consequence of Na+pump inhibition by ouabain. In addition , Ouabain itself concentration-dependently induced agradual contraction, which occurred after a delay of 10-25 min. This effect is due mainly to an increase in noradrenaline release via an effect on the Na+-dependent Ca2+ influx system. The selectivity of (-)-discretamine for α1-adrenoceptor subtypes was evaluated by use of functional and binding studies in rat vas deferens, spleen and aorta, and in cultured DDT1MF-2and A10 cells. The selectivity of (-)-discretamine among various α 1-adrenoceptor subtypes is α1A : α1B : α1D=0.04 : 0.07 : 1.0. N-methy-actinodaphnine is more selective for the α1b-than for the α1a-drenoceptor subtype. The effects of N-allylsecoboldine,(-)-discretamine, (± )-govadine, (±)-THP and N-methyl-actinodaphnine on human prostates were investigated. Amongtheng N-allylsecoboldine exhibits greater potency against contraction to electrical field stimulation than that to PE, while N-methyl- actinodaphnine has greater potency against PE-induced contraction than that to electrical field stumulation in human prostate. Teng Che-Ming、Ko Feng-Nien 鄧哲明、柯逢年 1996 學位論文 ; thesis 212 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
博士 === 國立臺灣大學 === 藥理學研究所 === 84 === In human prostate, both nifedipine and CEC produced
significant inhibition of NA-induced contractions. These
results indicated that NA-induced contractions in human
prostate are mediated by both α1A- and α 1B-
adrenoceptorsubtypes. In contrast, the putative α 1a-
adrenoceptors in human prostate may be functionally
confined to the synaptic region. Ouabain (1uM) did not
induce contractile response per se but progressively
increased the resting tone in human prostate. Form
our experimental results it is suggested that the increased
tone of human prostate following repeated excitation in the
presence of ouabain is due to increased Ca2+entry and
reduced efflux of Ca2+as a consequence of Na+pump
inhibition by ouabain. In addition , Ouabain itself
concentration-dependently induced agradual contraction, which
occurred after a delay of 10-25 min. This effect is due mainly
to an increase in noradrenaline release via an effect on
the Na+-dependent Ca2+ influx system. The selectivity of
(-)-discretamine for α1-adrenoceptor subtypes was evaluated
by use of functional and binding studies in rat vas
deferens, spleen and aorta, and in cultured DDT1MF-2and
A10 cells. The selectivity of (-)-discretamine among
various α 1-adrenoceptor subtypes is α1A : α1B : α1D=0.04
: 0.07 : 1.0. N-methy-actinodaphnine is more selective for
the α1b-than for the α1a-drenoceptor subtype.
The effects of N-allylsecoboldine,(-)-discretamine, (±
)-govadine, (±)-THP and N-methyl-actinodaphnine on human
prostates were investigated. Amongtheng N-allylsecoboldine
exhibits greater potency against contraction to electrical
field stimulation than that to PE, while N-methyl-
actinodaphnine has greater potency against PE-induced
contraction than that to electrical field stumulation in human
prostate.
|
author2 |
Teng Che-Ming、Ko Feng-Nien |
author_facet |
Teng Che-Ming、Ko Feng-Nien Guh Jih-Hwa 顧記華 |
author |
Guh Jih-Hwa 顧記華 |
spellingShingle |
Guh Jih-Hwa 顧記華 Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate |
author_sort |
Guh Jih-Hwa |
title |
Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate |
title_short |
Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate |
title_full |
Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate |
title_fullStr |
Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate |
title_full_unstemmed |
Characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate |
title_sort |
characterization of a1-adrenoceptor subtypes and pharmacological actions of their antagonists in human prostate |
publishDate |
1996 |
url |
http://ndltd.ncl.edu.tw/handle/66140564711167482123 |
work_keys_str_mv |
AT guhjihhwa characterizationofa1adrenoceptorsubtypesandpharmacologicalactionsoftheirantagonistsinhumanprostate AT gùjìhuá characterizationofa1adrenoceptorsubtypesandpharmacologicalactionsoftheirantagonistsinhumanprostate AT guhjihhwa rénlèiqiánlièxiànzǔzhīa1shènshàngxiànshòutǐyàxíngjíqíjiékàngjìyàolǐzuòyòngzhītàntǎo AT gùjìhuá rénlèiqiánlièxiànzǔzhīa1shènshàngxiànshòutǐyàxíngjíqíjiékàngjìyàolǐzuòyòngzhītàntǎo |
_version_ |
1718346334754308096 |